Stockscreener 앱 받기
57.76
0.21%
0.12
시간 외 거래:
57.92
0.16
+0.28%
전일 마감가:
$57.64
열려 있는:
$57.7
하루 거래량:
671.39K
Relative Volume:
0.76
시가총액:
$2.68B
수익:
$1.35B
순이익/손실:
$163.34M
주가수익비율:
17.63
EPS:
3.2763
순현금흐름:
$189.17M
1주 성능:
-2.66%
1개월 성능:
-26.72%
6개월 성능:
+7.20%
1년 성능:
-7.27%
1일 변동 폭
$57.44
$59.33
1주일 범위
$55.95
$60.49
52주 변동 폭
$47.31
$87.32
Haemonetics Corp Stock (HAE) Company Profile
명칭
Haemonetics Corp
전화
(781) 848-7100
주소
125 SUMMER STREET, BOSTON, MA
Compare HAE vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
57.76 | 2.68B | 1.35B | 163.34M | 189.17M | 3.2763 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 다운그레이드 | Needham | Buy → Hold |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-08-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | 재확인 | Barrington Research | Outperform |
| 2025-08-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-06-26 | 개시 | Robert W. Baird | Outperform |
| 2025-02-07 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-12-06 | 개시 | JP Morgan | Overweight |
| 2024-11-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | 개시 | CL King | Buy |
| 2024-09-11 | 개시 | BofA Securities | Neutral |
| 2024-09-10 | 개시 | BTIG Research | Buy |
| 2024-06-12 | 업그레이드 | Needham | Hold → Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-01-27 | 다운그레이드 | Needham | Buy → Hold |
| 2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-08-17 | 재개 | Raymond James | Outperform |
| 2021-06-17 | 개시 | Citigroup | Buy |
| 2021-05-14 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | 개시 | Needham | Buy |
| 2019-08-07 | 재확인 | Barrington Research | Outperform |
| 2019-05-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | 재확인 | Barrington Research | Outperform |
| 2018-08-09 | 재확인 | Barrington Research | Outperform |
| 2018-02-07 | 재확인 | Barrington Research | Outperform |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | 재확인 | Barrington Research | Outperform |
| 2017-08-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | 재확인 | The Benchmark Company | Hold |
| 2016-09-20 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2016-08-02 | 재확인 | Jefferies | Buy |
| 2016-08-02 | 재확인 | The Benchmark Company | Hold |
모두보기
Haemonetics Corp 주식(HAE)의 최신 뉴스
Haemonetics Corporation $HAE Shares Sold by Principal Financial Group Inc. - MarketBeat
Haemonetics (HAE) Balances Softer Interventional Sales With Buybacks – What Story Does Guidance Tell? - simplywall.st
Haemonetics Releases 2024-2025 Corporate Responsibility Report - TipRanks
5 Revealing Analyst Questions From Haemonetics's Q4 Earnings Call - Finviz
Skylands Capital LLC Has $3.97 Million Stock Holdings in Haemonetics Corporation $HAE - MarketBeat
Haemonetics (HAE) International Revenue Performance Explored - Yahoo Finance
Key Players in the Autotransfusion Systems MarketHaemonetics - openPR.com
Chuck Royce's Strategic Moves: Significant Reduction in Haemonetics Corp - Yahoo Finance
Why Haemonetics (HAE) is a Top Value Stock for the Long-Term - Yahoo Finance
A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $75 to $94 - 富途牛牛
Haemonetics Earnings Call: Strong Core, IVT Drag - TipRanks
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Haemonetics (HAE) and Denali Therapeutics (DNLI) - The Globe and Mail
Why Haemonetics (HAE) Raised 2026 Guidance After Strong Plasma And Tech Results And What It Signals - Yahoo Finance
Haemonetics (HAE) Margin Strength In Q3 2026 Reinforces Earnings Led Bullish Narratives - simplywall.st
Haemonetics Q3 Earnings Call Highlights - MarketBeat
Haemonetics (NYSE:HAE) Trading Down 5.6%Here's What Happened - MarketBeat
Haemonetics stock slides 7% as revenue dip and hospital softness blunt raised outlook - TechStock²
Citigroup Lowers Price Target for Haemonetics (HAE) to $75 | HAE Stock News - GuruFocus
Mizuho Lowers Haemonetics (HAE) Price Target, Maintains Outperfo - GuruFocus
Haemonetics (HAE) Rating Update: Barrington Research Raises Pric - GuruFocus
Haemonetics Q3 Earnings & Revenues Beat, Margins Up, Stock Slips - Yahoo Finance
Haemonetics' (HAE) "Buy" Rating Reaffirmed at BTIG Research - MarketBeat
Haemonetics Corporation (NYSE:HAE) Q3 2026 Earnings Call Transcript - Insider Monkey
Haemonetics price target raised to $94 from $93 at Barrington - TipRanks
Haemonetics (HAE) Valuation Check After Q3 Beat And Higher 2026 Guidance - simplywall.st
HAE Q4 Deep Dive: Plasma Momentum and Hospital Weakness Shape Mixed Results - Finviz
Haemonetics stock maintains Market Outperform rating at Citizens on strong plasma growth - Investing.com Nigeria
Haemonetics stock maintains Market Outperform rating at Citizens on strong plasma growth By Investing.com - Investing.com South Africa
BTIG Reiterates Buy Rating and $88 Price Target on HAE | HAE Sto - GuruFocus
Baird lowers Haemonetics stock price target to $81 on mixed outlook By Investing.com - Investing.com South Africa
Baird lowers Haemonetics stock price target to $81 on mixed outlook - Investing.com Nigeria
Decoding Haemonetics Corp (HAE): A Strategic SWOT Insight - GuruFocus
Haemonetics Q3 2026 slides: Margin expansion and cash flow surge despite revenue transition - Investing.com Canada
Haemonetics (NYSE:HAE) Announces Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
Haemonetics Corp (HAE) Q3 2026 Earnings Call Highlights: Strong - GuruFocus
Haemonetics reports Q3 adjusted EPS $1.31, consensus $1.25 - TipRanks
Haemonetics HAE Q3 2026 Earnings Call Transcript - AOL.com
Haemonetics (HAE) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
Haemonetics (HAE) Exceeds Q3 Revenue Expectations with Strong Pe - GuruFocus
Haemonetics's (NYSE:HAE) Q4 CY2025 Sales Top Estimates, Stock Soars - Finviz
Haemonetics (NYSE:HAE) Releases FY 2026 Earnings Guidance - MarketBeat
Haemonetics (HAE) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance
Haemonetics: Fiscal Q3 Earnings Snapshot - kare11.com
Haemonetics beats Q3 expectations, raises fiscal 2026 guidance By Investing.com - Investing.com Nigeria
Haemonetics beats Q3 expectations, raises fiscal 2026 guidance - Investing.com
Haemonetics’s (NYSE:HAE) Q4 CY2025 Sales Top Estimates, Stock Soars - Yahoo Finance
Haemonetics: Fiscal Third Quarter Earnings Overview - Bitget
Haemonetics earnings beat by $0.06, revenue topped estimates - Investing.com
Haemonetics Corporation Q3 Fiscal 2026 Results - TradingView
HAEMONETICS CORP SEC 10-Q Report - TradingView
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website - PR Newswire
Haemonetics Corp (HAE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.33%
0.51%
자본화:
|
볼륨(24시간):